CompletedPhase 3

Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice.

United States120 participantsStarted 2006-01

Plain-language summary

This is a multi-center, randomized, double blind, vehicle controlled, study designed to evaluate the pediculicidal activity of Summers 5% L.A. compared to a vehicle control.

Who can participate

Age range6 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males and females 6 months of age or older.
✓. Have an active infestation with pediculus capitis, the human head louse, with at least three live lice at baseline.
✓. Agree not to use any other pediculicides or medicated hair-grooming products during the duration of the study.
✓. Be healthy, non-febrile, and not suffering from an infection likely to require antibiotic therapy during the study period.
✓. Subject or guardian is able to understand the new HIPAA regulations and sign the HIPAA form.
✓. Subject or guardian has read, understood, and signed appropriate informed consent in English. If English is not the primary language, the information about the study must be explained in their language and a copy of the informed consent must be in that language.
✓. Subject is willing to participate in the study, and abide by the protocol requirements.

Exclusion criteria

✕. Participation in any clinical study within the past 30 days.
✕. Known hypersensitivity to any ingredient in the product formulation.

What they're measuring

Treatment success is defined as the absence of live lice.

Trial details

NCT IDNCT00301327

SponsorSummers Laboratories

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Head Lice trials